Skip to main content

Doxycycline Monohydrate

FDA recalls

3 rows

DateCompany and reasonClass
Apr 12, 2022McKesson Medical-Surgical Inc. Corporate Office
cGMP deviations: Temperature abuse
Class II · Terminated
Jan 25, 2022Cardinal Healthcare
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Terminated
Mar 12, 2020Sun Pharmaceutical Industries, Inc.
CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.
Class II · Terminated

← Back to Doxycycline Monohydrate

Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).